Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: Can we predict progression?

Brain

Volumn 130, Issue 6, 2007, Pages 1516-1524

  Auré, Karine ^a,b   Ogier De Baulny, Hélène ^c   Laforêt, Pascal ^a,d   Jardel, Claude ^a,d   Eymard, Bruno ^a,b,d   Lombès, Anne ^a,b,d  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CPEO; Deletion; Kearns Sayre syndrome; Mitochondrial disease; Natural history

Indexed keywords

MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL; CHEEK; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE DELETION; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INFANT; INNER EAR; KIDNEY CELL; MAJOR CLINICAL STUDY; MUSCLE CELL; ONSET AGE; OPHTHALMOPLEGIA; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETINA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; BLOOD; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; FOLLOW UP; GENE REARRANGEMENT; GENETICS; KEARNS SAYRE SYNDROME; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA, MITOCHONDRIAL; FOLLOW-UP STUDIES; GENE DELETION; GENE REARRANGEMENT; HUMANS; KEARNS-SAYER SYNDROME; MIDDLE AGED; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34250813636     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm067     Document Type: Article

References (34)

1. Auré K, Fayet G, Leroy JP, Lacène E, Romero NB, Lombès A. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation. Brain 2006; 129: 1249-59.
2. Bastiaensen LAK, Joosten EM, De Rooij JAM, Hommes OR, Stadhouders AM, Jaspar HHJ, et al. Ophthalmoplegia-plus, a real nosological entity. Acta Neurol Scand 1978; 58: 9-34.
3. Berenberg RA, Pellock JM, DiMauro S, Schotland DL, Bonilla E, Eastwood A, et al. Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol 1977; 1: 37-54.
4. Bernes SM, Bacino C, Prezant TR, Pearson MA, Wood TS, Fournier P, et al. Identical mitochondrial DNA deletion in mother with progressive external ophtalmoplegia and son with Pearson marrow-pancreas syndrome. J Pediatrics 1993; 123: 598-602.
5. Brockington M, Alsanjari N, Sweeney MG, Morgan-Hughes JA, Scaravilli F, Harding AE. Kearns-Sayre syndrome associated with mitochondrial DNA deletion or duplication: a molecular genetic and pathological study. J Neurol Sci 1995; 131: 78-87.
6. Butler IJ, Gadoth N. Kearns-Sayre syndrome. A review of a multisystem disorder of children and young adults. Arch Intern Med 1976; 136: 1290-3.
7. Cheng G, Litchenberg WH, Cole GJ, Mikawa T, Thompson RP, Gourdie RG. Development of the cardiac conduction system involves recruitment within a multipotent cardiomyogenic lineage. Development 1999; 126: 5041-9.
8. Chinnery PF, Johnson MA, Wardell TM, Singh-Kler R, Hayes C, Brown DT, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000; 48: 188-93.
9. Drachman DA. Ophthalmoplegia plus: the neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 1968; 18: 654-74.
10. Gerbitz KD, Obermaier-Kusser B, Zierz S, Pongratz D, Müller- Höcker J, Lestienne P. Mitochondrial myopathies: divergence of genetic deletions, biochemical defects and the clinical syndromes. J Neurol 1990; 237: 5-10.
11. Hammans SR, Sweeney MG, Wicks DAG, Morgan-Hughes JA, Harding AE. A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathies. Brain 1992; 115: 343-65.
12. Holt IJ, Harding AE, Cooper JM, Schapira AHV, Toscano A, Clark JB, et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989; 26: 699-708.
13. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-9.
14. Hurko O, Johns DR, Rutledge SL, Stine OC, Peterson PL, Miller NR, et al. Heteroplasmy in chronic external ophthalmoplegia: clinical and molecular observations. Pediatr Res 1990; 28: 542-8.
15. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol (Chicago) 1958; 60: 280.
16. Lacbawan F, Tifft CJ, Luban NL, Schmandt SM, Guerrera M, Weinstein S, et al. Clinical heterogeneity in mitochondrial DNA deletion disorders: a diagnostic challenge of Pearson syndrome. Am J Med Genet 2000; 95: 266-8.
17. Larsson NG, Holme E, Kristiansson B, Oldfors A, Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990; 28: 131-6.
18. Manfredi G, Vu T, Bonilla E, Schon EA, DiMauro S, Arnaudo E, et al. Association of myopathy with large-scale mitochondrial DNA duplications and deletions: which is pathogenic? Ann Neurol 1997; 42: 180-8.
19. McShane MA, Hammans SR, Sweeney M, Holt IJ, Beattie TJ, Brett EM, et al. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991; 48: 39-42.
20. Moraes CT, DiMauro S, Zeviani M, Lombès A, Shanske S, Miranda A, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-9.
21. Odoardi F, Rana M, Broccolini A, Mirabella M, Modoni A, D'Amico A, et al. Pathogenic role of mtDNA duplications in mitochondrial diseases associated with mtDNA deletions. Am J Med Genet A 2003; 118: 247-54.
22. Oldfors A, Larsson NG, Holme E, Tulinius M, Kadenbach B, Droste M. Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres. J Neurol Sci 1992; 110: 169-77.
23. Pearson HA, Lobel JS, Kocoshis SA, Naiman JW, Windmuller J, Lammi AT, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatrics 1979; 95: 976-84.
24. Poulton J, Deadman ME, Ramacharan S, Gardiner RM. Germ-line deletions of mtDNA in mitochondrial myopathy. Am J Hum Genet 1991; 48: 649-53.
25. Poulton J, Morten KJ, Weber K, Brown GK, Bindoff L. Are duplications of mitochondrial DNA characteristic of Kearns-Sayre syndrome? Hum Mol Genet 1994; 3: 947-51.
26. Remes AM, Majamaa-Voltti K, Karppa M, Moilanen JS, Uimonen S, Helander H, et al. Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population. Neurology 2005; 64: 976-81.
27. Rotig A, Bourgeron T, Chretien D, Rustin P, Munnich A. Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 1995; 4: 1327-30.
28. Sciacco M, Bonilla E, Schon EA, DiMauro S, Moraes CT. Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet 1994; 3: 13-9.
29. Shanske S, Moraes CT, Lombès A, Miranda AF, Bonilla E, Lewis P, et al. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology 1990; 40: 24-8.
30. Shanske S, Tang Y, Hirano M, Nishigaki Y, Tanji K, Bonilla E, et al. Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with pearson syndrome. Am J Hum Genet 2002; 71: 679-83.
31. Shy GM, Silberberg DH, Appel SH, Mishkin MM, Godfrey EH. A generalized disorder of nervous system, skeletal muscle and heart resembling Refsum's disease and Hurler's syndrome. I. Clinical, pathologic and biochemical characteristics. Am J Med 1967; 42: 163-8.
32. Yamamoto M, Clemens PR, Engel AG. Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patients. Neurology 1991; 41: 1822-8.
33. Zeviani M, Gellera C, Pannacci M, Uziel G, Prelle A, Servidei S, et al. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann Neurol 1990; 28: 94-7.
34. Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988; 38: 1339-46.